Remimazolam meets noninferiority to propofol for delirium; esketamine cuts chronic pain after thoracoscopic resection; VR eases preoperative anxiety

An anesthesia face mask with a clear shell and cushioned rim, joined by corrugated breathing tubing to a reservoir bag.

A randomized trial of 686 patients, published Oct. 29 in the British Journal of Anaesthesia, found remimazolam-based anesthesia noninferior to propofol for postoperative delirium after neurovascular surgery.

A 914-patient trial found perioperative esketamine lowered chronic pain after thoracoscopic lung resection, and a 106-patient trial found a single virtual reality session reduced anxiety before ambulatory surgery.

  • Research Oct 29, 2026
    In a single-center, double-blind randomized trial of adults having elective neurovascular surgery, published Oct. 29 in the British Journal of Anaesthesia, remimazolam-based total intravenous anesthesia with flumazenil reversal met noninferiority to propofol-based anesthesia for delirium within five days, the primary end point. Delirium occurred in 12.8% (44 of 344) with remimazolam and 10.8% (37 of 342) with propofol (risk difference 1.97 percentage points; 95% CI -2.85 to 6.80), within a 10-point margin. Extubation in the operating room was more frequent with remimazolam (85.2% versus 67.3%). The authors said delirium was less common than anticipated when the margin was set.
  • Research Oct 28, 2026
    In a multicenter, double-blind randomized trial registered in China, published Oct. 28 in the British Journal of Anaesthesia, low-dose esketamine given as a bolus at induction, an intraoperative infusion and a 48-hour postoperative infusion reduced chronic pain three months after video-assisted thoracoscopic lung resection to 14.7% from 21.2% with saline (adjusted odds ratio 0.62; 95% CI 0.43 to 0.90; P = .013), the primary end point. Of 914 randomized adults, 873 were analyzed. The authors said esketamine did so without increasing adverse effects.
  • Technology Oct 26, 2026
    In the single-center, open-label AMBLUMEEN randomized trial in Lyon, France, published Oct. 26 in Anesthesia & Analgesia, 106 ambulatory surgery patients with moderate to severe anxiety received standard care with or without one 20-minute immersive virtual reality session before surgery. The adjusted mean between-group difference in change in State-Trait Anxiety Inventory score was -18.7 points (95% CI -21.4 to -16.1) in favor of virtual reality, the primary end point. Benzodiazepine use, postoperative pain and unplanned overnight admission were comparable between groups.

The weekly innovation roundup for anesthesiology, published every Sunday for the week before; every item links to its sources. Latest anesthesiology news · All specialties

Latest news

Tagged anesthesiology, from the daily briefing

  1. FDA classifies spinal imaging systems for neuraxial procedures into class II
  2. Remimazolam vs. propofol anesthesia: postoperative delirium 12.8% vs. 10.8% in 686 neurovascular surgery patients
  3. Perioperative low-dose esketamine lowered 3-month chronic pain after thoracoscopic lung resection, 14.7% vs. 21.2%

See all the latest news